Inventor · disambiguated record
Alexander Karpeisky
Also filed as: KARPEISKY ALEXANDER
27 granted patents·15 pending applications·3,792 citations·filing 1994–2022
97Inventor score
Files withRIBOZYME PHARM INC17SIRNA THERAPEUTICS INC10MBC PHARMA INC7KARPEISKY ALEXANDER2MAXWELL BIOTECH GROUP LTD2
Top patents by PatentIndex Score
42 records- 0199US5627053A2'deoxy-2'-alkylnucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 1995·Granted May 6, 1997·1.5k cites·5 claims
- 0298US6673611B2Nucleic acid molecules with novel chemical compositions capable of modulating gene expressionSIRNA THERAPEUTICS INC·Filed 2001·Granted Jan 6, 2004·218 cites·17 claims
- 0398US5998203AEnzymatic nucleic acids containing 5'-and/or 3'-cap structuresRIBOZYME PHARM INC·Filed 1996·Granted Dec 7, 1999·784 cites·41 claims
- 0497US6248878B1Nucleoside analogsRIBOZYME PHARM INC·Filed 1997·Granted Jun 19, 2001·264 cites·16 claims
- 0596US6617438B1Oligoribonucleotides with enzymatic activitySIRNA THERAPEUTICS INC·Filed 1999·Granted Sep 9, 2003·312 cites·27 claims
- 0696US6528640B1Synthetic ribonucleic acids with RNAse activityRIBOZYME PHARM INC·Filed 1999·Granted Mar 4, 2003·283 cites·3 claims
- 0795US7553830B2Compositions for the delivery of negatively charged moleculesSIRNA THERAPEUTICS INC·Filed 2005·Granted Jun 30, 2009·20 cites·10 claims
- 0895US6159951A2'-O-amino-containing nucleoside analogs and polynucleotidesRIBOZYME PHARM INC·Filed 1997·Granted Dec 12, 2000·136 cites·18 claims
- 0990US6686463B2Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivativesSIRNA THERAPEUTICS INC·Filed 2001·Granted Feb 3, 2004·59 cites·75 claims
- 1090US5985621A2'-deoxy-2'-alkylnucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 1996·Granted Nov 16, 1999·63 cites·12 claims
- 1185US9216204B2Bone targeted therapeutics and methods of making and using the sameMBC PHARMA INC·Filed 2013·Granted Dec 22, 2015·6 cites·8 claims
- 1285US8586781B2Bone targeted therapeutics and methods of making and using the sameKARPEISKY ALEXANDER·Filed 2009·Granted Nov 19, 2013·7 cites·7 claims
- 1383US6972330B2Chemical synthesis of methoxy nucleosidesSIRNA THERAPEUTICS INC·Filed 2003·Granted Dec 6, 2005·16 cites·12 claims
- 1483US6586238B1Enzymatic nucleic acids containing 5′-and or 3′-cap structuresRIBOZYME PHARM INC·Filed 1999·Granted Jul 1, 2003·43 cites·20 claims
- 1582US5639647A2'-deoxy-2'alkylnucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 1994·Granted Jun 17, 1997·41 cites·34 claims
- 1677US6509460B1Nucleoside triphosphates and their incorporation into oligonucleotidesRIBOZYME PHARM INC·Filed 2000·Granted Jan 21, 2003·4 cites·12 claims
- 1776US2009221807A12' Deoxy-2'-Alkylnucleotide Containing Nucleic AcidSIRNA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1873US2010036115A1Novel Compositions for the Delivery of Negatively Charged MoleculesSIRNA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1972US10046055B2Bone targeted therapeutics and methods of making and using the sameMBC PHARMA INC·Filed 2015·Granted Aug 14, 2018·1 cites·11 claims
- 2070US6127535ANucleoside triphosphates and their incorporation into oligonucleotidesRIBOZYME PHARM INC·Filed 1998·Granted Oct 3, 2000·23 cites·20 claims
- 2168US6365374B12′-deoxy-2′-alkylnucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 1999·Granted Apr 2, 2002·13 cites·6 claims
- 2266US6482932B1Nucleoside triphosphates and their incorporation into oligonucleotidesRIBOZYME PHARM INC·Filed 1999·Granted Nov 19, 2002·21 cites·20 claims
- 2365US6506888B12′-O-amino-containing nucleoside analogs and polynucleotidesRIBOZYME PHARM INC·Filed 2000·Granted Jan 14, 2003·1 cites·4 claims
- 2465US2022323474A1Drug combination treatments using bone-targeting therapeutics for bone and bone-related diseaseMBC Pharma·Filed 2022·Application pending·0 cites
- 2563US9334300B2Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonatesKARPEISKY ALEXANDER·Filed 2012·Granted May 10, 2016·1 cites·10 claims
- 2663US5962675AChemical syntheses of 2'-O-methoxy purine nucleosidesRIBOZYME PHARM INC·Filed 1996·Granted Oct 5, 1999·15 cites·12 claims
- 2762US2006142557A12'-deoxy-2'alkylnucleotide containing nucleic acidSIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2860US2002197684A12'-deoxy-2'-alkylnucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 2002·Application pending·0 cites
- 2959US2018339055A1Bone targeted therapeutics and methods of making and using the sameMBC PHARMA INC·Filed 2018·Application pending·0 cites
- 3058US2005176018A1Chemically modified double stranded nucleic acid moleculesSIRNA THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 3157US2005074760A1Enzymatic nucleic acids containing 5'-and/or 3'-cap structuresRIBOZYME PHARM INC·Filed 2003·Application pending·0 cites
- 3255US11324767B2Drug combination treatments using bone-targeting therapeutics for bone and bone-related diseaseMBC PHARMA INC·Filed 2018·Granted May 10, 2022·0 cites·12 claims
- 3355US2005059817A1Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivativesSIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3451US2014315851A1Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonatesMBC PHARMA INC·Filed 2014·Application pending·0 cites
- 3550US2003130186A1Conjugates and compositions for cellular deliveryFiled 2002·Application pending·0 cites
- 3647US2002150936A1Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivativesFiled 2002·Application pending·0 cites
- 3745US2003073640A1Novel compositions for the delivery of negatively charged moleculesRIBOZYME PHARM INC·Filed 2001·Application pending·0 cites
- 3843US11298366B2Ibandronate conjugates of nucleoside antimetabolitesMBC PHARMA INC·Filed 2018·Granted Apr 12, 2022·0 cites·18 claims
- 3943US2016250247A1Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonatesMBC PHARMA INC·Filed 2016·Application pending·0 cites
- 4043US2003004122A1Nucleotide triphosphates and their incorporation into oligonucleotidesFiled 2001·Application pending·0 cites
- 4142US11219603B2Stable dosage form of etidronate-cytarabine conjugate, and use thereofMAXWELL BIOTECH GROUP LTD·Filed 2016·Granted Jan 11, 2022·0 cites·18 claims
- 4234US11045487B2Pharmaceutical preparation treating bone lesions caused by malignant neoplasmsMAXWELL BIOTECH GROUP LTD·Filed 2017·Granted Jun 29, 2021·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Alexander Karpeisky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →